Heart failure: Current concepts

Medical Journal Armed Forces India

Volumn 59, Issue 4, 2003, Pages 283-285

  Singh, Charanjit ^a   Sabharwal, J S ^b  

^a MILITARY HOSPITAL   (India)

^b Department of Laboratory Medicine and Transfusion Medicine   (India)

Author keywords

Diastolic dysfunction; Heart failure; Systolic dysfunction

Indexed keywords

ACETYLSALICYLIC ACID; ADRENERGIC RECEPTOR BLOCKING AGENT; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; INOTROPIC AGENT; LOOP DIURETIC AGENT; METOPROLOL; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

AGE; ANGIONEUROTIC EDEMA; ARTIFICIAL HEART PACEMAKER; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL EXAMINATION; CLINICAL TRIAL; COUGHING; DIASTOLE; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG EFFICACY; EDITORIAL; HEART FAILURE; HEART SURGERY; HUMAN; INCIDENCE; MORTALITY; PATHOPHYSIOLOGY; RISK FACTOR; SYSTOLE;

EID: 0142242167     PISSN: 03771237     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0377-1237(03)80135-1     Document Type: Editorial

References (6)

1. Khand A, Gemmel I, Clark AL, Cleland JG. Is the prognosis of heart failure improving? J Am Coll Cardiol 2000;36:2284-6.
2. Hunt SA, Baker DW, Chin MH et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2001;38:2101-13.
3. Sutton MGSJ, Sharpe N. Left ventricular remodelling after myocardial infarction : pathophysiology and therapy. Circulation 2000;101:2981-8.
4. Grossman W, Angeja B. Evaluation and management of diastolic heart failure. Circulation 2003;107:659-63.
5. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53.
6. McMurray J, Pfeffer MA. New therapeutic options in congestive heart failure. Circulation 2002;105:2099-106, 2223-8.